The TGF-β family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase

Genes and Development

Volumn 11, Issue 8, 1997, Pages 984-995

  Kretzschmar, Marcus ^a   Liu, Fang ^a   Hata, Akiko ^a   Doody, Jacqueline ^a   Massagué, Joan ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

BMP; DPC4; phosphorylation; receptor; Smad1; TGF

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CELL RECEPTOR; PROTEIN SERINE THREONINE KINASE; SERINE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CARBOXY TERMINAL SEQUENCE; ENZYME SUBSTRATE; GENETIC TRANSCRIPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALIA; VERTEBRATA;

EID: 0030911104     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.11.8.984     Document Type: Article

References (61)

1. Attisano, L., J. Cárcamo, F. Ventura, F.M.B. Weis, J. Massagué, and J.L. Wrana. 1993. Identification of human Activin and TGF-β type I receptors that form heteromeric kinase complexes with type II receptors. Cell 75: 671-680.
2. Attisano, L., J.L. Wrana, F. López-Casillas, and J. Massagué. 1994. TGF-β receptors and actions. Biochim. Biophys. Acta 1222: 71-80.
3. Attisano, L., J.L. Wrana, E. Montalvo, and J. Massagué. 1996. Activation of signaling by the activin receptor complex. Mol. Cell. Biol. 16: 1066-1073.
4. Baker, J. and R.M. Harland. 1996. A novel mesoderm inducer, mMadr-2, functions in the activin signal transduction pathway. Genes & Dev. 10: 1880-1889.
5. Barrett, M.T., M. Schutte, S.E. Kern, and B.J. Reid. 1996. Allelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma. Cancer Res. 56: 4351-4353.
6. Border, W.A. and E. Ruoslahti. 1992. Transforming growth factor-β in disease: The dark side of tissue repair. J. Clin. Invest. 90: 1-7.
7. Boyle, W.J., P. van der Geer, and T. Hunter. 1991. Phosphopeptide mapping and phosphoamino acid analysis by two-di-mensional separation on thin-layer cellulose plates. Methods Enzymol. 201B: 110-149.
8. Cárcamo, J., F.M.B. Weis, F. Ventura, R. Wieser, J.L. Wrana, L. Attisano, and J. Massagué. 1994. Type I receptors specify growth inhibitory and transcriptional responses to TGF-β and activin. Mol. Cell Biol. 14: 3810-3821.
9. Cárcamo, J., A. Zentella, and J. Massagué. 1995. Disruption of TGF-β signaling by a mutation that prevents transphosphorylation within the receptor complex. Mol. Cell. Biol. 15: 1573-1581.
10. Chen, W.J., D.A. Andres, J.L. Goldstein, and M.S. Brown. 1991. Cloning and expression of a cDNA encoding the alpha subunit of rat p21ras protein farnesyltransferase. Proc. Natl. Acad. Sci. 88: 11368-11372.
11. Chen, X., M.J. Rubock, and M. Whitman. 1996. A transcriptional partner of MAD proteins in TGF-β signaling. Nature 383: 691-696.
12. Chen, Y.G., F. Lin, and J. Massagué. 1997. Mechanism of TGFβ receptor inhibition by FKBP12. EMBO J. (in press).
13. Darnell, J.E.J. 1996. Reflections on STAT3, STAT5, and STAT6 as fat STATs. Proc. Natl. Acad. Sci. 93: 6221-6224.
14. Derynck, R. and Y. Zhang. 1996. Intracellular signaling: The Mad way to do it. Curr. Biol. 6: 1226-1229.
15. Eppert, K., S.W. Scherer, H. Ozcelik, R. Pirone, P. Hoodless, H. Kim, L.-C. Tsui, B. Bapat, S. Gallinger, I.L. Andrulis, G.H. Thomsen, J.L. Wrana, and L. Attisano. 1996. MADR2 maps to 18q21 and encodes a TGF-β-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86: 543-552.
16. Franzén, P., P. ten Dijke, H. Ichijo, H. Yamashita, P. Schulz, C.-H. Heldin, and K. Miyazono. 1993. Cloning of a TGF-β type I receptor that forms a heteromeric complex with the TGF-β type II receptor. Cell 75: 681-692.
17. Fynan, T.M. and M. Reiss. 1993. Resistance to inhibition of cell growth by transforming growth factor-b and its role in oncogenesis. Crit. Rev. Oncol. 4: 493-540.
18. Graff, J.M., A. Bansal, and D.A. Melton. 1996. Xenopus Mad proteins transduce distinct subsets of signals for the TGFβ superfamily. Cell 85: 479-487.
19. Hahn, S.A., M. Schutte, A.T.M.S. Hoque, C.A. Moskaluk, L.T. da Costa, E. Rozenblum, C.L. Weinstein, A. Fischer, C.J. Yeo, R.H. Hruban, and S.E. Kern. 1996. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271: 350-353.
20. Harlow, E. and D. Lane. 1988. Antibodies: A laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
21. Hogan, B.L.M. 1996. Bone morphogenetic proteins: Multifunctional regulators of vertebrate development. Genes & Dev. 10: 1580-1594.
22. Hoodless, P.A., T. Haerry, S. Abdollah, M. Stapleton, M.B. O'Connor, L. Attisano, and J.L. Wrana. 1996. MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell 85: 489-500.
23. Hunter, T. 1995. Protein kinases and phosphatases: The yin and yang of protein phosphorylation and signaling. Cell 80: 225-236.
24. Ihle, J.N. 1996. STATs: Signal transducers and activators of transcription. Cell 84: 331-334.
25. Kawabata, M., T. Imamura, K. Miyazono, M.E. Engel, and H.L. Moses. 1995. Interaction of the transforming growth factor-β type I receptor with farnesyl-protein transferase-α. J. Biol. Chem. 270: 29628-29631.
26. Kim, S.K., Y. Fan, V. Papadimitrakopoulou, G. Clayman, W.N. Hittelman, W.K. Hong, R. Lotan, and L. Mao. 1996. DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma. Cancer Res. 56: 2519-2521.
27. Kingsley, D.M. 1994. The TGF-β superfamily: New members, new receptors, and new genetic tests of function in different organisms. Trends Genet. 10: 16-21.
28. Kretzschmar, M., M. Meisterernst, C. Scheidereit, G. Li, and R.G. Roeder. 1992. Transcriptional regulation of the HIV-1 promoter by NF-κB in vitro. Genes & Dev. 6: 761-774.
29. Lagna, G., A. Hata, A. Hemmati-Brivanlou, and J. Massagué. 1996. Partnership between DPC4 and SMAD proteins in TGF-β signaling pathways. Nature 383: 832-836.
30. Lechleider, R.J., M.P. de Caestecker, A. Dehejia, M.H. Polymeropoulos, and A.B. Roberts. 1996. Serine, phosphorylation, chromosomal localization and TGF-β signal transduction by human bsp-1. J. Biol. Chem. 271: 17617-17620.
31. Lillie, J.W. and M.R. Green. 1989. Transcription activation by the adenovirus E1a protein. Nature 338: 39-44.
32. Liu, F., F. Ventura, J. Doody, and J. Massagué. 1995. Human type II receptor for bone morphogenetic proteins (BMPs): Extension of the two-kinase receptor model to the BMPs. Mol. Cell. Biol. 15: 3479-3486.
33. Liu, F., A. Hata, J. Baker, J. Doody, J. Cárcamo, R. Harland, and J. Massagué. 1996. A human Mad protein acting as a BMP-regulated transcriptional activator. Nature 381: 620-623.
34. Luo, K., P. Zhou, and H.F. Lodish. 1995. The specificity of the transforming growth factor β receptor kinases determined by a spatially addressable peptide library. Proc. Natl. Acad. Sci. 92: 11761-11765.
35. Macias-Silva, M., S. Abdollah, P.A. Hoodless, R. Pirone, L. Attisano, and J.L. Wrana. 1996. MADR2 is a substrate of the TGF-β receptor and phosphorylation is required for nuclear accumulation and signaling. Cell 87: 1215-1224.
36. Markowitz, S.D. and A.B. Roberts. 1996. Tumor suppressor activity of the TGF-β pathway in human cancers. Cytokine Growth Factor Rev. 7: 93-102.
37. Massagué, J. 1992. Receptors for the TGF-β family. Cell 69: 1067-1070.
38. _. 1996. TGF-β signaling: Receptors, transducers and Mad proteins. Cell 85: 947-950.
39. Massagué, J. and F. Weis-Garcia. 1996. Serine/threonine kinase receptors: Mediators of TGF-β family signals. Cell signaling 27: 41-64.
40. Miyazono, K., P. ten Dijke, H. Ichijo, and C.-H. Heldin. 1994. Receptors for transforming growth factor-β. Adv. Immunol. 55: 181-220.
41. Nagatake, M., Y. Takagi, H. Osada, K. Uchida, T. Mitsudomi, S. Saji, K. Shimokata, T. Takahashi, and T. Takahashi. 1996. Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers. Cancer Res. 56: 2718-2720.
42. Okadome, T., E. Oeda, M. Saitoh, H. Ichijo, H.L. Moses, K. Miyazono, and M. Kawabata. 1996. Characterization of the interaction of FKBP12 with the transforming growth factor-β type I receptor in vivo. J. Biol. Chem. 271: 21687-21690.
43. Riggins, G.J., S. Thiagalingam, E. Rozenblum, C.L. Weinstein, S.E. Kern, S.R. Hamilton, J.K.V. Willson, S.D. Markowitz, K.W. Kinzler, and B. Vogelstein. 1996. Mad-related genes in the human. Nature Genet. 13: 347-349.
44. Roberts, A.B. and M.B. Sporn, eds. 1990. The transforming growth factor-betas. In Peptide growth factors and their receptors, pp. 419-472. Springer-Verlag, Heidelberg, Germany.
45. Savage, C., P. Das, A. Finelli, S.R. Townsend, C.-Y. Sun, S.E. Baird, and R.W. Padgett. 1996. Caenorhabditis elegans genes sma-2, sma-3 and sma-4 define a conserved family of transforming growth factor β pathway components. Proc. Natl. Acad. Sci. 93: 790-794.
46. Schlessinger, J. and D. Bar-Sagi. 1994. Activation of Ras and other signaling pathways by receptor tyrosine kinases. Cold Spring Harbor Symp. Quant. Biol. 59: 173-179.
47. Schutte, M., R.H. Hruban, L. Hedrik, K.R. Cho, G.M. Nadasdy, C.L. Weinstein, G.S. Bova, W.B. Isaacs, P. Cairns, H. Nawroz, D. Sidransky, C.A. Casero, P.S. Meltzer, S.A. Hahn, and S.E. Kern. 1996. DPC4 gene in various tumor types. Cancer Res. 56: 2527-2530.
48. Sekelsky, J.J., S.J. Newfeld, L.A. Raftery, E.H. Chartoff, and W.M. Gelbart. 1995. Genetic characterization and cloning of Mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster. Genetics 139: 1347-1358.
49. ten Dijke, P., H. Yamashita, T.K. Sampath, A.H. Reddi, M. Estevez, D.L. Riddle, H. Ichijo, C.-H. Heldin, and K. Miyazono. 1994. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J. Biol. Chem. 269: 16985-16988.
50. Thomsen, G. 1996. Xenopus mothers against decapentaplegic is an embryonic ventralizing agent that acts downstream of the BMP-2/4 receptor. Development 122: 2359-2366.
51. Uchida, K., M. Nagatake, H. Osada, Y. Yatabe, M. Kondo, T. Mitsudomi, A. Masuda, T. Takahashi, and T. Takahashi. 1996. Somatic in vivo alterations of the JV18-1 gene at 18q21 in human lung cancers. Cancer Res. 56: 5583-5585.
52. Ventura, F., F. Liu, J. Doody, and J. Masagué. 1996. Transforming growth factor-β receptor type I interacts with farnesyl transferase-α in yeast and mammalian cells. J. Biol. Chem. 271: 13931-13934.
53. Wang, T., P.K. Donahoe, and A.S. Zervos. 1994. Specific interaction of type I receptors of the TGF-β family with the immunophilin FKBP-12. Science 265: 674-676.
54. Wang, T., P.D. Danielson, B. Li, P.C. Shah, S.D. Kim, and P.K. Donahoe. 1996a. The p21RAS farnesyltransferase α subunit in TGF-β and activin signaling. Science 271: 1120-1122.
55. Wang, T., B.-Y. Li, P.D. Danielson, P.C. Shah, S. Rockwell, R.J. Lechleider, J. Martin, T. Mangnaro, and P.K. Donahoe. 1996b. The immunophilin FKBP12 functions as a common inhibitor of the TGFβ family type I receptors. Cell 86: 435-444.
56. Weis-Garcia, F. and J. Massagué. 1996. Complementation between kinase-defective and activation-defective TGF-β receptors reveals a novel form of receptor cooperativity essential for signaling. EMBO J. 15: 276-289.
57. Wiersdorff, V., T. Lecuit, S.M. Cohen, and M. Mlodzik. 1996. Mad acts downstream of Dpp receptors, revealing a differential requirement for dpp signaling in initiation and propogation of morphogenesis in the Dropsophila eye. Development 122: 2153-2162.
58. Wieser, R., J.L. Wrana, and J. Massagué. 1995. GS domain mutations that constitutively activate TβR-I, the downstream signaling component in the TGF-β receptor complex. EMBO J. 14: 2199-2208.
59. Wrana, J.L., L. Attisano, R. Wieser, F. Ventura, and J. Massagué. 1994. Mechanism of activation of the TGF-β receptor. Nature 370: 341-347.
60. Yingling, J.M., P. Das, C. Savage, C. Zhang, R.W. Padgett, and X.-F. Wang. 1996. Mammalian Dwarfins are phosphorylated in response to TGF-β and are implicated in control of cell growth. Proc. Natl. Acad. Sci. 93: 8940-8944.
61. Zhang, Y., X.-H. Feng, R.-Y. Wu, and R. Derynck. 1996. Receptor-associated Mad homologues synergize as effectors of the TGFβ response. Nature 383: 168-172.